TRIGLYCERIDE - GLUCOSE INDEX CORRESPONDING TO THE RISK OF CARDIOVASCULAR EVENTS ACCORDING TO THE FRAMINGHAM RISK SCORE AND SCORE_VN
Main Article Content
Abstract
Background: Patients (PTs) with atherosclerosis are at high risk of major adverse cardiovascular events, including cardiovascular death, stroke, and non-fatal myocardial infarction. The Triglyceride - Glucose (TyG) index is believed to be associated with future cardiovascular events. Objectives: To determine the Triglyceride - Glucose Index cut-off point corresponding to intermediate and high cardiovascular risk groups according to the Framingham Risk Score (FRS) and SCORE_VN in individuals with cardiometabolic risk factors. Subjects and research methods: A descriptive cross-sectional study was performed on 223 patients with cardiometabolic risk factors, aged 40 to 69, at Cardiology Outpatient Clinic, University Medical Center Ho Chi Minh City, Campus 1, from September to December 2024. Results: The area under the curve (AUC) of the TyG index for FRS and SCORE_VN was 0.74 (95% CI: 0.67 – 0.81; p < 0.001) and 0.67 (95% CI: 0.60 – 0.74; p < 0.001), respectively. The cut-off points of the TyG index for the intermediate and high cardiovascular risk groups according to FRS and SCORE_VN were both 9.0 (sensitivity 65.0%, specificity 72.4%, positive predictive value 46.4%, negative predictive value 84.9% for FRS and sensitivity 54.2%, specificity 74.8%, positive predictive value 61.9%, negative predictive value 68.3% for SCORE_VN). Conclusion: The TyG index has a fair value in predicting the risk of future cardiovascular events according to FRS and SCORE_VN with the TyG cut-off point at 9.0.
Article Details
Keywords
Triglyceride - Glucose, Framingham, SCORE_VN, major adverse cardiovascular events, cardiometabolic syndrome
References

2. Group SBR. Risk of fatal coronary heart disease in familial hypercholesterolaemia. BMJ: British Medical Journal. 1991:893-896.

3. Liu Q, Zhang Y, Chen S, et al. Association of the triglyceride-glucose index with all-cause and cardiovascular mortality in patients with cardiometabolic syndrome: a national cohort study. Cardiovasc Diabetol. Feb 24 2024;23(1): 80. doi:10.1186/s12933-024-02152-y


4. Sánchez‐Íñigo L, Navarro‐González D, Fernández‐Montero A, Pastrana‐Delgado J, Martínez JA. The TyG index may predict the development of cardiovascular events. European journal of clinical investigation. 2016;46(2):189-197.

5. Tao S, Yu L, Li J, et al. Association between the triglyceride-glucose index and 1-year major adverse cardiovascular events in patients with coronary heart disease and hypertension. Cardiovasc Diabetol. Nov 8 2023;22(1):305. doi:10.1186/s12933-023-02018-9


6. Wang L, Cong HL, Zhang JX, et al. Triglyceride-glucose index predicts adverse cardiovascular events in patients with diabetes and acute coronary syndrome. Cardiovasc Diabetol. Jun 13 2020;19(1):80. doi:10.1186/ s12933-020-01054-z


7. World Health Organization. Noncommunicable diseases country profiles 2018. 2018:218.

8. Xue Y, Xu J, Li M, Gao Y. Potential screening indicators for early diagnosis of NAFLD/MAFLD and liver fibrosis: Triglyceride glucose index-related parameters. Front Endocrinol (Lausanne). 2022;13:951689. doi:10.3389/fendo.2022.951689

